Brief: atai Life Sciences AG Announces Equity Investment In And Strategic Partnership With IntelGenx Technologies Corp
March 17 (Reuters) - atai Life Sciences AG:
* ATAI LIFE SCIENCES AG ANNOUNCES EQUITY INVESTMENT IN AND
STRATEGIC PARTNERSHIP WITH INTELGENX TECHNOLOGIES CORP.
* ATAI LIFE SCIENCES -AGREED TO PURCHASE 37.3 MILLION NEWLY
ISSUED
COMMON STOCK UNITS OF INTELGENX FOR GROSS PROCEEDS OF US$12.3
MILLION
* ATAI LIFE SCIENCES AG - EACH UNIT IS COMPRISED OF ONE
COMMON
SHARE AND THREE-FIFTHS OF ONE COMMON STOCK PURCHASE WARRANT
Source text for Eikon: ID:nCNWrgm1Ra
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA